Ambev (ABEV) Stock Forecast & Price Target

$2.29 +0.04 (+1.78%)

As of 03:58 PM Eastern

Ambev - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 5 Analyst Ratings

Sell
1

Hold
3

Buy
1

Based on 5 Wall Street analysts who have issued ratings for Ambev in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 3 have given a hold rating, and 1 has given a buy rating for ABEV.

Consensus Price Target

$2.45
6.99% Upside

According to the 5 analysts' twelve-month price targets for Ambev, the average price target is $2.45. The highest price target for ABEV is $2.90, while the lowest price target for ABEV is $2.00. The average price target represents a forecasted upside of 6.99% from the current price of $2.29.

Get the Latest News and Ratings for ABEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ambev and its competitors.

ABEV Analyst Ratings Over Time

Type	Current Forecast 4/14/24 to 4/14/25	1 Month Ago 3/15/24 to 3/15/25	3 Months Ago 1/15/24 to 1/14/25	1 Year Ago 4/15/23 to 4/14/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	3 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$2.45	$2.45	$2.70	$3.20
Forecasted Upside	6.99% Upside	6.29% Upside	49.58% Upside	36.17% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Remove Ads

ABEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ABEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ambev Stock vs. The Competition

Type	Ambev	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.00	2.54	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	6.99% Upside	74.79% Upside	25.81% Upside
News Sentiment Rating	Neutral News See Recent ABEV News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/7/2025	Morgan Stanley 3 of 5 stars		Downgrade	Equal Weight ➝ Underweight
1/22/2025	Citigroup 2 of 5 stars	Renata Cabral Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
1/21/2025	Barclays 3 of 5 stars	Benjamin Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$2.50 ➝ $2.00	+12.04%
1/17/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
7/31/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$3.20 ➝ $2.90	+40.78%
3/1/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Neutral
11/22/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$2.86	+4.57%
5/24/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$3.74	+29.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:33 AM ET.

Should I Buy Ambev Stock? ABEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, April 7, 2025. Please send any questions or comments about these Ambev pros and cons to contact@marketbeat.com.

Ambev
Bull Case

Here are some ways that investors could benefit from investing in Ambev S.A.:

Recent increase in institutional investment, with Foresight Global Investors Inc. boosting its stake by 41.1%, indicating strong confidence in the company's future performance.
Schroder Investment Management Group raised its position by 72.2%, reflecting a significant commitment to Ambev S.A. and suggesting positive growth potential.
Current stock price is $2.36, which may present a buying opportunity for investors looking for value in the beverage sector.
Analysts have a consensus target price of $2.45, suggesting potential upside from the current trading price, which could attract investors seeking capital appreciation.
Ambev S.A. has a relatively low debt-to-equity ratio of 0.02, indicating strong financial health and lower risk compared to companies with higher leverage.

Ambev
Bear Case

Investors should be bearish about investing in Ambev S.A. for these reasons:

Barclays recently lowered its price target from $2.50 to $2.00, which may signal a lack of confidence in the stock's short-term performance.
Bank of America downgraded Ambev S.A. from a "buy" to a "neutral" rating, indicating a more cautious outlook on the company's growth prospects.
Market volatility has been high, with recent trading volumes fluctuating significantly, which could lead to increased risk for investors.
Only 8.13% of the stock is owned by institutional investors and hedge funds, suggesting limited institutional confidence compared to other companies in the sector.
Ambev S.A. has received mixed ratings from analysts, with three holding a "hold" rating and only two assigning a "buy" rating, indicating uncertainty in its market position.

ABEV Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Ambev is $2.45, with a high forecast of $2.90 and a low forecast of $2.00.
: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ambev in the last year. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ABEV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABEV, but not buy additional shares or sell existing shares.
: According to analysts, Ambev's stock has a predicted upside of 6.99% based on their 12-month stock forecasts.
: Over the previous 90 days, Ambev's stock had 2 downgrades by analysts.
: Ambev has been rated by research analysts at Bank of America, Barclays, Citigroup, and Morgan Stanley in the past 90 days.
: Analysts like Ambev less than other "consumer staples" companies. The consensus rating for Ambev is Hold while the average consensus rating for "consumer staples" companies is Moderate Buy. Learn more on how ABEV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:ABEV) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ambev (ABEV) Stock Forecast & Price Target